Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development

Background: mRNA-based cancer vaccines have been considered a promising anticancer therapeutic approach against various cancers, yet their efficacy for malignant mesothelioma (MESO) is still not clear. The present study is designed to identify MESO antigens that have the potential for mRNA vaccine d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuhang, Yang, Yuqi, Li, Lu, Ma, Peiwen, Jiang, Yale, Ge, Minghui, Yu, Yue, Huang, Huiyao, Fang, Yuan, Jiang, Ning, Miao, Huilei, Guo, Hao, Yan, Linlin, Ren, Yong, Sun, Lichao, Zha, Yan, Li, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331978/
https://www.ncbi.nlm.nih.gov/pubmed/35893817
http://dx.doi.org/10.3390/vaccines10081168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331978/
https://www.ncbi.nlm.nih.gov/pubmed/35893817
http://dx.doi.org/10.3390/vaccines10081168

Ejemplares similares